Genomic Landscape of Meningiomas

Meningiomas are one of the most common adult brain tumors. For most patients, surgical excision is curative. However, up to 20% recur. Currently, the molecular determinants predicting recurrence and malignant transformation are lacking. We performed retrospective global genetic and genomic analysis of 85 meningioma samples of various grades. Copy number alterations were assessed by 100K single‐nucleotide polymorphism arrays and correlated with gene expression, proliferation indices and clinical outcome. In addition to chromosome 22q loss, which was detected in the majority of clinical samples, chromosome 6q and 14q loss was significantly more common in recurrent tumors and was associated with anaplastic histology. Five “classes” of meningiomas were detected by gene expression analysis that correlated with copy number alterations, recurrent status and malignant histology. These classes more accurately identified recurrent tumors relative to Ki‐67 index and extent of surgical resection, and highlight substantial expression heterogeneity between meningiomas. These data offer the most complete description of the genomic landscape of meningiomas, and provide broad genomic information that may be used to further stratify meningioma patients into prognostic risk groups.

[1]  S. Nelson,et al.  Celsius: a community resource for Affymetrix microarray data , 2007, Genome Biology.

[2]  John Y. K. Lee,et al.  Loss of Heterozygosity Analysis of Benign, Atypical, and Anaplastic Meningiomas , 2004, Neurosurgery.

[3]  F. Kokocinski,et al.  Microarray‐based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression , 2005, International journal of cancer.

[4]  V. Stieber,et al.  Meningioma: Current treatment options and future directions , 2004, Current treatment options in oncology.

[5]  Hui Yue,et al.  Expression of cell cycle regulator p57kip2, cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: an immunohistochemical study. , 2005, World journal of gastroenterology.

[6]  T. Golub,et al.  Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. , 2003, Cancer research.

[7]  Z. Rappaport,et al.  Non-Resectable Slow-Growing Meningiomas Treated by Hydroxyurea , 2004, Journal of Neuro-Oncology.

[8]  M. Westphal,et al.  Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. , 1999, Cancer genetics and cytogenetics.

[9]  D. Gutmann,et al.  Meningioma: an update , 2004, Current opinion in neurology.

[10]  S. Horvath,et al.  Gene Expression Profiling of Gliomas Strongly Predicts Survival , 2004, Cancer Research.

[11]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[12]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[13]  M. McDermott,et al.  Surgical Resection and Permanent Brachytherapy for Recurrent Atypical and Malignant Meningioma , 2004, Neurosurgery.

[14]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[15]  P. Wesseling,et al.  Secondary meningioma in a long-term survivor of atypical teratoid/rhabdoid tumour with a germline INI1 mutation , 2008, Child's Nervous System.

[16]  Arie Perry,et al.  Molecular pathogenesis of meningiomas , 2004, Journal of Neuro-Oncology.

[17]  Mark W. Youngblood,et al.  Molecular genetics of meningiomas. , 2020, Handbook of clinical neurology.

[18]  I. Dunham,et al.  The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Roe,et al.  Structure of the promoter and genomic organization of the human beta'-adaptin gene (BAM22) from chromosome 22q12. , 1996, Genomics.

[20]  S. Vandenberg,et al.  Molecular signatures define two main classes of meningiomas , 2007, Molecular Cancer.

[21]  Robert Henke,et al.  High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs. , 2005, American journal of human genetics.

[22]  K. Sasaki,et al.  Comparative Genomic Hybridization Analysis of Genetic Alterations Associated with Malignant Progression of Meningioma , 2004, Journal of Neuro-Oncology.

[23]  Paul S Mischel,et al.  Gene expression profiling identifies molecular subtypes of gliomas , 2003, Oncogene.

[24]  Peter S White,et al.  Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34 , 2004, Oncogene.

[25]  Arie Perry,et al.  Histological classification and molecular genetics of meningiomas , 2006, The Lancet Neurology.

[26]  P H Riegman,et al.  Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. , 1995, Oncogene.

[27]  A. Deimling,et al.  INI1 mutations in meningiomas at a potential hotspot in exon 9 , 2001, British Journal of Cancer.

[28]  J. Sawyer,et al.  Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. , 2004, Journal of neurosurgery.

[29]  M. West,et al.  Gene expression profiling and genetic markers in glioblastoma survival. , 2005, Cancer research.

[30]  S. Groshen,et al.  Temozolomide for treatment-resistant recurrent meningioma , 2004, Neurology.

[31]  S. Toyooka,et al.  Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. , 2004, Oncology reports.

[32]  I. Newsham,et al.  Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. , 2000, Human molecular genetics.

[33]  N. Mailand,et al.  Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation , 2002, Nature Cell Biology.

[34]  Michael Egmont-Petersen,et al.  Genome-wide Copy Number Profiling on High-density Bacterial Artificial Chromosomes, Single-nucleotide Polymorphisms, and Oligonucleotide Microarrays: A Platform Comparison based on Statistical Power Analysis , 2007, DNA research : an international journal for rapid publication of reports on genes and genomes.

[35]  Shern-Fwu Lee,et al.  Survival Factor Withdrawal-induced Apoptosis of TF-1 Cells Involves a TRB2-Mcl-1 Axis-dependent Pathway* , 2007, Journal of Biological Chemistry.

[36]  Paul S Mischel,et al.  Identification of molecular subtypes of glioblastoma by gene expression profiling , 2003, Oncogene.